Growth Metrics

Bruker (BRKR) Cash from Investing Activities Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -253.01%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -11.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -41.67%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -6.88%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -472.46%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -16.93%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -111.03%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -40.94%
10 Bruker 8.89 Bn 8.77 Bn 379.80 Mn 28.41%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 28.41%
Dec 31, 2025 28.10%
Sep 30, 2025 25.52%
Jun 30, 2025 -53.20%
Mar 31, 2025 36.47%
Dec 31, 2024 -7.63%
Sep 30, 2024 -11.78%
Jun 30, 2024 -164.75%
Mar 31, 2024 -133.16%
Dec 31, 2023 -8.51%
Sep 30, 2023 -47.60%
Jun 30, 2023 -19.86%
Mar 31, 2023 -2.46%
Dec 31, 2022 -56.17%
Sep 30, 2022 -65.97%
Jun 30, 2022 39.50%
Mar 31, 2022 -56.22%
Dec 31, 2021 32.25%
Sep 30, 2021 -18.48%
Jun 30, 2021 -15.70%
Mar 31, 2021 -30.49%
Dec 31, 2020 -38.33%
Sep 30, 2020 -44.53%
Jun 30, 2020 33.22%
Mar 31, 2020 -12.16%
Dec 31, 2019 0.92%
Sep 30, 2019 -38.61%
Jun 30, 2019 -138.58%
Mar 31, 2019 -53.38%
Dec 31, 2018 -53.05%
Sep 30, 2018 7.94%
Jun 30, 2018 -42.89%
Mar 31, 2018 175.74%
Dec 31, 2017 38.77%
Sep 30, 2017 42.51%
Jun 30, 2017 12.20%
Mar 31, 2017 -108.20%
Dec 31, 2016 -68.66%
Sep 30, 2016 43.81%
Jun 30, 2016 33.66%
Mar 31, 2016 19.72%
Dec 31, 2015 -16.61%
Sep 30, 2015 -34.59%
Jun 30, 2015 4.07%
Mar 31, 2015 44.02%
Dec 31, 2014 -31.67%
Sep 30, 2014 -94.41%
Jun 30, 2014 -49.54%
Mar 31, 2014 7.86%
Dec 31, 2013 67.32%
Sep 30, 2013 -25.78%
Jun 30, 2013 25.53%
Mar 31, 2013 -38.35%